Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endogenous Mechanisms of Inactivation of the Endothelium Tumor

NCT03667612 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.

NCT NCT03667612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03667612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endogenous Mechanisms of Inactivation of the Endothelium Tumor
Lead sponsor
Centre Oscar Lambret
Phase
Observational
Overall status
Completed
Start date
January 31, 2018
Completion date
October 31, 2019
Enrollment
70 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, colon cancer